Cannabis Law in the Philippines (2026): Dangerous Drugs Act, CBD Permits and Pending Bills

Cannabis, its resin and its seeds are dangerous drugs in the Philippines. Selling, importing or growing any amount can bring life imprisonment, although the death penalty has been prohibited since 2006. The only legal medical route is a case-by-case permit for finished medicines, and the medical cannabis bills before Congress are not law.

The short answer

  • Recreational use: banned. A first positive drug test means at least six months in a government rehabilitation centre.
  • Medical cannabis: no programme. CBD medicines with no more than 0.1% THC, or medicines registered abroad, can be allowed for one patient at a time with permits.
  • CBD and hemp: CBD products outside that permit route are dangerous drugs. Hemp cannot be grown.
  • Penalties: possession brings 12 years and 1 day or more. Importing, selling or growing any amount brings life imprisonment and a fine of up to ₱10 million.
  • Travel: bringing cannabis, CBD or seeds into the country without a permit counts as importing a dangerous drug.

The laws that apply

  • Comprehensive Dangerous Drugs Act of 2002 (Republic Act No. 9165), passed by both houses of Congress in May 2002. It defines cannabis as every kind of Cannabis sativa L. “and seeds thereof”, “whether as a reefer, resin, extract, tincture or in any form whatsoever”.
  • Republic Act No. 9346, approved on 24 June 2006. It prohibits the death penalty and replaces it with life imprisonment or reclusion perpetua (the life sentence of the Revised Penal Code).
  • Dangerous Drugs Board Regulation No. 8, Series of 2019, adopted on 17 December 2019. It sets a licence for unregistered medicines that contain dangerous drugs, for personal use.
  • Dangerous Drugs Board Regulation No. 3, Series of 2020, adopted on 24 September 2020. It moves CBD drug products with no more than 0.1% THC into Schedule 4 of the Philippine Schedule, a lower control level.

The Dangerous Drugs Board (DDB) sets drug policy. The Philippine Drug Enforcement Agency (PDEA) enforces the law. The Food and Drug Administration (FDA) issues permits for unregistered medicines.

Medical cannabis

There is no medical cannabis programme. No law allows growing cannabis, or selling flower or cannabis oil, for patients.

There are two narrow routes, both for finished medicines:

  • CBD medicines with no more than 0.1% THC. Regulation No. 3 covers products “in finished pharmaceutical dosage form”. The prescriber must hold an S2 licence (a licence to prescribe dangerous drugs) and belong to a neurology society. The patient needs a DDB Authorization and an FDA Compassionate Special Permit.
  • Medicines registered in reference countries but not in the Philippines. Under Regulation No. 8 the patient or a family member applies to PDEA for a licence. It covers conditions such as rare diseases, cancer and terminal illness.

In February 2020 the DDB said Epidiolex may be used through compassionate use (press). No official source showed that it is registered in the Philippines.

If a doctor has suggested a cannabinoid medicine, ask a neurologist with an S2 licence to start the DDB and FDA applications.

CBD and hemp

Regulation No. 3 notes that “extracts and tinctures of cannabis, which includes cannabidiol” are in Schedule I of the Single Convention on Narcotic Drugs (1961). So any CBD product outside the permit route stays a dangerous drug. The 0.1% THC limit applies only to finished CBD medicines. There is no THC limit for plants or other products.

Hemp has no separate place in the law; the definition even names “Indian Hemp”. Growing any amount falls under Section 16, and there is no hemp licence.

If you sell CBD or hemp goods, treat the Philippines as closed except for registered or permitted medicines.

Penalties

The Act still says “life imprisonment to death” for the most serious offences. Because of Republic Act No. 9346, the highest penalty in practice is life imprisonment.

Offence (Republic Act No. 9165) Amount Penalty
Importing (Section 4), selling, delivering or transporting (Section 5) any amount life imprisonment and ₱500,000 to ₱10 million
Growing (Section 16) any amount life imprisonment and ₱500,000 to ₱10 million
Possession (Section 11) 500 g or more of cannabis; 10 g or more of resin or resin oil life imprisonment and ₱500,000 to ₱10 million
Possession 300 g to under 500 g; resin 5 g to under 10 g 20 years and 1 day to life, and ₱400,000 to ₱500,000
Possession under 300 g; resin under 5 g 12 years and 1 day to 20 years, and ₱300,000 to ₱400,000
Use, first offence (Section 15) — at least six months in a government rehabilitation centre
Use, second offence — 6 years and 1 day to 12 years, and ₱50,000 to ₱200,000

A few more rules matter:

  • Selling has no weight threshold. There is no presumption of trafficking by weight; selling and importing are punished “regardless of the quantity and purity”.
  • Parties and groups (Section 13): possession at a party, or with at least two other people, brings the maximum possession penalty, whatever the amount.
  • Paraphernalia (Section 12): 6 months and 1 day to 4 years, and it counts as evidence of use.
  • No probation for traffickers (Section 24). People serving reclusion perpetua cannot get parole.
  • Foreigners (Section 31): they are deported immediately after serving their sentence.
  • The Act has no provision on offences committed abroad, and there is no caning.

Under the party rule, a small amount shared in a group can bring the heaviest possession penalty.

Travelling with cannabis medicines, CBD or seeds

  • Cannabis, CBD and seeds: bringing any of them in without a permit is importing a dangerous drug under Section 4. The penalty is life imprisonment and up to ₱10 million, whatever the amount.
  • Medicines with a dangerous drug: the PDEA licence under Regulation No. 8 must be obtained “prior to actual acquisition, possession, and use”. The application must state how the medicine will be transported, including “personal transport by patient or authorized family members”. Failing to comply can lead to prosecution under the Act.
  • CBD medicines with no more than 0.1% THC: the DDB Authorization and FDA permit come first.

For border routes from Thailand and seizure cases, read Taking Cannabis From Thailand to Other Asian Countries: Land and Air Routes, Seizures and Penalties. If you need a medicine, get the licence before you buy it, not at the airport.

Changes under way

None of the bills below is law.

  • House of Representatives: several bills were filed in the 20th Congress, including House Bill No. 1115, the “Access to Medical Cannabis Act” (2 July 2025). On 24 February 2026 two House committees approved a consolidated bill (press). It would create a Medical Cannabis Office in the Department of Health and licensed Medical Cannabis Compassionate Centers. Cannabis would stay a dangerous drug.
  • Stage: a bill reaches the House plenary only after a committee report. Up to Committee Report No. 701 (10 November 2026), none concerned cannabis, so the bill was still at committee stage.
  • Senate: Senator Robinhood Padilla refiled the “Cannabis Medicalization Act of the Philippines” on 30 June 2025 (press). No Senate hearing or vote was found in 2026.
  • Earlier attempts: the House passed medical cannabis bills on third reading in January 2019 and July 2024, but neither became law. The Senate version stalled in June 2025 (press).

If you plan to export medical cannabis to the Philippines, wait for a passed law and its implementing rules before you plan sales.

Related reading on Asiannabis

References

  1. Republic Act No. 9165 — An Act Instituting the Comprehensive Dangerous Drugs Act of 2002, Repealing Republic Act No. 6425 — The Lawphil Project, 2002
  2. Republic Act No. 9346 — An Act Prohibiting the Imposition of Death Penalty in the Philippines — The Lawphil Project, 24 June 2006
  3. Board Regulation No. 3, Series of 2020 — Placing Drug Products Containing Cannabidiol (CBD) with No More Than 0.1 Percent Tetrahydrocannabinol in Schedule 4 of the Philippine Schedule — Dangerous Drugs Board, 24 September 2020
  4. Board Regulation No. 8, Series of 2019 — Requirements for the Issuance of a License to Acquire, Possess, and Use Unregistered Drug Products Containing Dangerous Drugs for Personal Use — Dangerous Drugs Board, 17 December 2019
  5. Board Regulation — Dangerous Drugs Board list of regulations, checked 16 November 2026
  6. DDB approves new regulation for dangerous drugs — The Philippine Star, 5 January 2020
  7. Medical marijuana still illegal, only ‘compassionate use’ is allowed —DDB — GMA News, 17 February 2020
  8. House Bill No. 1115, Twentieth Congress — An Act Providing Right to Access to Medical Cannabis, Establishing the Medical Cannabis Office and Providing Funds Therefor — House of Representatives, 2 July 2025
  9. House panels revive medical cannabis bill — Daily Tribune, 24 February 2026
  10. House panels OK bill to legalize medical cannabis, emphasizing strict regulations and patient access — BusinessMirror, 24 February 2026
  11. Committee Reports No. 1–701, Twentieth Congress — House of Representatives, up to 10 November 2026
  12. Robin Padilla renews push for legalizing medical marijuana in the Philippines — Bombo Radyo News, 1 July 2025
  13. Philippine House of Representatives approves proposed Medical Cannabis Act — Asia News Network, 31 July 2024
  14. Medical cannabis bill has fighting chance in 20th Congress — The Philippine Star, 14 July 2025

This page summarises the law as checked up to 16 November 2026. It is general information, not legal advice.